Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
Filed with HKEX · Stock code 6855 · · 10 pages · English
Summary by 6ix AI
It reports on the movements in authorized and registered share capital, confirming a total authorized share capital at the end of the month. The document also includes details on issued shares, treasury shares, and public float sufficiency confirmation. Additionally, it provides confirmations regarding compliance with listing rules and other regulatory requirements.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Ascentage Pharma Group International on 6ix
Earlier from Ascentage Pharma Group International
- Voluntary announcement - acquisition of shares by the chairman and executive director
- Voluntary announcement - purchase of shares by the trustee for the purpose of the 2022 RSU scheme
- Interim report 2026
- Ascentage Pharma Reports 2026 Interim Unaudited Financial Results and Provides Business Updates
- CORRECTION: Ascentage Pharma to Report 2026 Six Month Interim Results and Provide Corporate Update on August 19, 2026
Later from Ascentage Pharma Group International
All Ascentage Pharma Group International news releasesFollow Ascentage Pharma Group International into a list and get an email when it puts out news.
Follow Ascentage Pharma Group International